Trade Zepp Health - ZEPP CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.0568 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026207% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003985% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Zepp Health Corp ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
Prev. Close* | 1.4366 |
Open* | 1.4366 |
1-Year Change* | -11.14% |
Day's Range* | 1.4366 - 1.5066 |
52 wk Range | 0.96-2.19 |
Average Volume (10 days) | 59.38K |
Average Volume (3 months) | 953.70K |
Market Cap | 82.40M |
P/E Ratio | -100.00K |
Shares Outstanding | 244.15M |
Revenue | 415.88M |
EPS | -0.64 |
Dividend (Yield %) | N/A |
Beta | 0.92 |
Next Earnings Date | Mar 19, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 8, 2023 | 1.4766 | 0.0800 | 5.73% | 1.3966 | 1.5066 | 1.3866 |
Dec 7, 2023 | 1.4366 | 0.1100 | 8.29% | 1.3266 | 1.5066 | 1.2766 |
Dec 6, 2023 | 1.4566 | -0.0300 | -2.02% | 1.4866 | 1.6066 | 1.3966 |
Dec 5, 2023 | 1.5266 | -0.2100 | -12.09% | 1.7366 | 1.8366 | 1.4866 |
Dec 4, 2023 | 1.7666 | 0.2000 | 12.77% | 1.5666 | 1.8766 | 1.5666 |
Dec 1, 2023 | 1.5166 | 0.2100 | 16.07% | 1.3066 | 1.5266 | 1.2966 |
Nov 30, 2023 | 1.3366 | 0.0600 | 4.70% | 1.2766 | 1.3766 | 1.2766 |
Nov 29, 2023 | 1.2666 | 0.0300 | 2.43% | 1.2366 | 1.3366 | 1.2366 |
Nov 28, 2023 | 1.2466 | 0.0100 | 0.81% | 1.2366 | 1.3366 | 1.2166 |
Nov 27, 2023 | 1.2366 | 0.1100 | 9.76% | 1.1266 | 1.3066 | 1.1266 |
Nov 24, 2023 | 1.1166 | 0.0000 | 0.00% | 1.1166 | 1.1866 | 1.1166 |
Nov 22, 2023 | 1.1566 | -0.0900 | -7.22% | 1.2466 | 1.3166 | 1.1566 |
Nov 21, 2023 | 1.2566 | -0.0100 | -0.79% | 1.2666 | 1.3466 | 1.2566 |
Nov 20, 2023 | 1.2466 | 0.0700 | 5.95% | 1.1766 | 1.3366 | 1.1766 |
Nov 17, 2023 | 1.1466 | -0.0100 | -0.86% | 1.1566 | 1.2066 | 1.1166 |
Nov 16, 2023 | 1.1666 | 0.0400 | 3.55% | 1.1266 | 1.2066 | 1.1266 |
Nov 15, 2023 | 1.1366 | 0.0200 | 1.79% | 1.1166 | 1.1966 | 1.1066 |
Nov 14, 2023 | 1.1266 | 0.0100 | 0.90% | 1.1166 | 1.1366 | 1.1066 |
Nov 13, 2023 | 1.1266 | 0.0300 | 2.74% | 1.0966 | 1.1466 | 1.0966 |
Nov 10, 2023 | 1.1066 | 0.0000 | 0.00% | 1.1066 | 1.1066 | 1.1066 |
Zepp Health Events
Time (UTC) | Country | Event |
---|---|---|
Wednesday, December 13, 2023 | ||
Time (UTC) 06:00 | Country US
| Event Zepp Health Corp Annual Shareholders Meeting Zepp Health Corp Annual Shareholders MeetingForecast -Previous - |
Tuesday, March 19, 2024 | ||
Time (UTC) 12:30 | Country US
| Event Q4 2023 Zepp Health Corp Earnings Release Q4 2023 Zepp Health Corp Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 4142.86 | 6250.11 | 6433.36 | 5812.25 | 3645.33 |
Revenue | 4142.86 | 6250.11 | 6433.36 | 5812.25 | 3645.33 |
Cost of Revenue, Total | 3339.75 | 4944.47 | 5100.7 | 4344.51 | 2705.89 |
Gross Profit | 803.116 | 1305.64 | 1332.67 | 1467.74 | 939.45 |
Total Operating Expense | 4566.96 | 6156.17 | 6202.65 | 5208.37 | 3287.21 |
Selling/General/Admin. Expenses, Total | 696.236 | 696.619 | 620.46 | 430.437 | 310.511 |
Research & Development | 517.122 | 515.081 | 538.009 | 430.822 | 263.22 |
Operating Income | -424.1 | 93.942 | 230.718 | 603.884 | 358.129 |
Interest Income (Expense), Net Non-Operating | 7.747 | -14.691 | 58.443 | 35.3 | 19.716 |
Other, Net | 43.82 | 27.418 | -23.552 | 13.186 | 8.768 |
Net Income Before Taxes | -372.533 | 106.669 | 265.609 | 652.37 | 386.613 |
Net Income After Taxes | -306.658 | 95.924 | 234.455 | 574.483 | 334.577 |
Equity In Affiliates | 17.657 | 41.028 | -4.749 | -1.112 | 1.743 |
Net Income Before Extra. Items | -288.308 | 137.803 | 228.753 | 575.196 | 340.046 |
Net Income | -288.308 | 137.803 | 228.753 | 575.196 | 340.046 |
Total Adjustments to Net Income | -2.45 | -226.556 | |||
Income Available to Common Excl. Extra. Items | -288.308 | 137.803 | 228.753 | 572.746 | 113.49 |
Income Available to Common Incl. Extra. Items | -288.308 | 137.803 | 228.753 | 572.746 | 113.49 |
Diluted Net Income | -288.308 | 137.803 | 228.753 | 572.746 | 113.49 |
Diluted Weighted Average Shares | 246.283 | 264.369 | 260.352 | 255.959 | 225.035 |
Diluted EPS Excluding Extraordinary Items | -1.17064 | 0.52125 | 0.87863 | 2.23765 | 0.50432 |
Dividends per Share - Common Stock Primary Issue | |||||
Diluted Normalized EPS | -1.13406 | 0.52125 | 0.687 | 2.24659 | 0.53351 |
Minority Interest | 0.693 | 0.851 | -0.953 | 1.825 | 3.726 |
Total Extraordinary Items | |||||
Unusual Expense (Income) | 13.858 | 0 | -56.522 | 2.6 | 7.59 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 648.343 | 645.183 | 1071.73 | 1205.79 | 1108.29 |
Revenue | 648.343 | 645.183 | 1071.73 | 1205.79 | 1108.29 |
Cost of Revenue, Total | 505.801 | 542.338 | 849.885 | 975.106 | 909.945 |
Gross Profit | 142.542 | 102.845 | 221.846 | 230.687 | 198.343 |
Total Operating Expense | 720.716 | 796.091 | 1156.54 | 1279.05 | 1218.89 |
Selling/General/Admin. Expenses, Total | 125.622 | 135.879 | 178.456 | 176.565 | 179.949 |
Research & Development | 89.293 | 117.874 | 114.341 | 127.382 | 128.991 |
Operating Income | -72.373 | -150.908 | -84.809 | -73.26 | -110.597 |
Interest Income (Expense), Net Non-Operating | -2.579 | -5.824 | 7.786 | -19.241 | -23.373 |
Other, Net | -0.783 | -1.985 | -0.514 | 38.269 | 2.32 |
Net Income Before Taxes | -75.735 | -158.717 | -77.537 | -54.232 | -131.65 |
Net Income After Taxes | -64.123 | -133.983 | -75.033 | -20.626 | -118.632 |
Minority Interest | 0.185 | 0.194 | 0.195 | 0.127 | 0.237 |
Equity In Affiliates | -6.003 | -2.931 | -0.71 | 3.409 | 11.45 |
Net Income Before Extra. Items | -69.941 | -136.72 | -75.548 | -17.09 | -106.945 |
Net Income | -69.941 | -136.72 | -75.548 | -17.09 | -106.945 |
Income Available to Common Excl. Extra. Items | -69.941 | -136.72 | -75.548 | -17.09 | -106.945 |
Income Available to Common Incl. Extra. Items | -69.941 | -136.72 | -75.548 | -17.09 | -106.945 |
Diluted Net Income | -69.941 | -136.72 | -75.548 | -17.09 | -106.945 |
Diluted Weighted Average Shares | 243.551 | 245.134 | 244.846 | 245.117 | 245.703 |
Diluted EPS Excluding Extraordinary Items | -0.28717 | -0.55774 | -0.30855 | -0.06972 | -0.43526 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.28717 | -0.55774 | -0.27176 | -0.06972 | -0.43526 |
Unusual Expense (Income) | 13.858 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 2958.55 | 3930.95 | 4827.87 | 4392.45 | 2857.46 |
Cash and Short Term Investments | 920.948 | 1492.85 | 2296.78 | 1820.3 | 1589.25 |
Cash & Equivalents | 886.632 | 1473.5 | 2278.35 | 1803.12 | 1538.77 |
Short Term Investments | 34.316 | 19.351 | 18.43 | 17.187 | 50.482 |
Total Receivables, Net | 870.316 | 1087.93 | 1280 | 1663.96 | 757.474 |
Accounts Receivable - Trade, Net | 820.717 | 832.698 | 1158.25 | 1610.11 | 715.324 |
Total Inventory | 1021.92 | 1249.33 | 1217.54 | 893.806 | 484.622 |
Prepaid Expenses | 55.44 | 58.994 | 26.737 | 11.724 | 11.623 |
Other Current Assets, Total | 89.921 | 41.856 | 6.816 | 2.661 | 14.484 |
Total Assets | 5267.64 | 6085.5 | 5903.72 | 5174.74 | 3258.48 |
Property/Plant/Equipment, Total - Net | 166.178 | 242.308 | 275.784 | 173.032 | 40.042 |
Property/Plant/Equipment, Total - Gross | 278.416 | 313.14 | 312.171 | 194.47 | 52.071 |
Accumulated Depreciation, Total | -112.238 | -70.832 | -36.387 | -21.438 | -12.029 |
Goodwill, Net | 66.081 | 61.055 | 62.515 | 5.93 | 5.93 |
Intangibles, Net | 123.3 | 135.582 | 145.213 | 85.753 | 63.722 |
Long Term Investments | 1686.63 | 1552.59 | 443.986 | 406.099 | 208.949 |
Other Long Term Assets, Total | 260.575 | 163.012 | 148.355 | 111.477 | 82.382 |
Total Current Liabilities | 1668.67 | 2152.13 | 2789.67 | 2481.8 | 1387.69 |
Accounts Payable | 497.563 | 1367.43 | 1962.52 | 2014.72 | 1074.8 |
Accrued Expenses | 92.646 | 139.701 | 134.678 | 256.077 | 154.303 |
Notes Payable/Short Term Debt | 968.438 | 461.795 | 504.671 | 2.184 | 38.936 |
Other Current Liabilities, Total | 110.021 | 183.207 | 187.805 | 208.819 | 119.652 |
Total Liabilities | 2595.12 | 3165.15 | 3173.46 | 2673.99 | 1447.57 |
Total Long Term Debt | 684.21 | 726.851 | 60 | 0 | 0 |
Deferred Income Tax | 35.552 | 26.909 | 22.374 | 5.399 | 4.962 |
Minority Interest | 12.399 | 13.092 | 0 | -3.162 | -1.337 |
Other Liabilities, Total | 194.292 | 246.17 | 301.413 | 189.956 | 56.249 |
Total Equity | 2672.52 | 2920.35 | 2730.26 | 2500.75 | 1810.92 |
Preferred Stock - Non Redeemable, Net | |||||
Common Stock | 0.162 | 0.159 | 0.157 | 0.155 | 0.151 |
Additional Paid-In Capital | 1690.88 | 1641.54 | 1552.11 | 1478.9 | 1373.58 |
Retained Earnings (Accumulated Deficit) | 942.848 | 1271.17 | 1133.37 | 910.612 | 340.046 |
Other Equity, Total | 105.796 | 29.271 | 44.624 | 111.081 | 97.141 |
Total Liabilities & Shareholders’ Equity | 5267.64 | 6085.5 | 5903.72 | 5174.74 | 3258.48 |
Total Common Shares Outstanding | 251.201 | 251.201 | 250.145 | 247.52 | 241.68 |
Redeemable Preferred Stock | 0 | ||||
Long Term Debt | 684.21 | 726.851 | 60 | ||
Treasury Stock - Common | -67.163 | -21.798 | |||
Note Receivable - Long Term | 6.333 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 2504.32 | 2612.16 | 2595.02 | 2958.55 | 3456.28 |
Cash and Short Term Investments | 952.849 | 1044.8 | 996.258 | 920.948 | 983.519 |
Cash & Equivalents | 928.22 | 1013.92 | 961.478 | 886.632 | 945.509 |
Short Term Investments | 24.629 | 30.882 | 34.78 | 34.316 | 38.01 |
Total Receivables, Net | 578.93 | 643.912 | 626.966 | 820.717 | 856.889 |
Accounts Receivable - Trade, Net | 578.93 | 643.912 | 626.966 | 820.717 | 856.889 |
Total Inventory | 786.962 | 742.571 | 799.933 | 1021.92 | 1375.12 |
Prepaid Expenses | 127.787 | 125.831 | 126.873 | 108.252 | 175.524 |
Other Current Assets, Total | 57.794 | 55.04 | 44.988 | 86.708 | 65.231 |
Total Assets | 4833.05 | 4929.89 | 4898.93 | 5267.64 | 5821.07 |
Property/Plant/Equipment, Total - Net | 111.63 | 117.361 | 142.142 | 166.178 | 189.889 |
Goodwill, Net | 69.902 | 69.474 | 65.797 | 66.081 | 68.153 |
Intangibles, Net | 104.862 | 108.971 | 119.038 | 123.3 | 128.873 |
Long Term Investments | 1696.28 | 1694.78 | 1681.38 | 1686.63 | 1713.39 |
Other Long Term Assets, Total | 339.223 | 320.404 | 289.205 | 260.575 | 264.487 |
Total Current Liabilities | 1222.61 | 1358.5 | 1204.01 | 1668.67 | 2096.13 |
Accounts Payable | 479.777 | 472.824 | 364.18 | 497.563 | 869.973 |
Accrued Expenses | 152.566 | 150.396 | 157.007 | 197.819 | 210.928 |
Notes Payable/Short Term Debt | 566.37 | 716.457 | 669.542 | 968.438 | 971.228 |
Other Current Liabilities, Total | 23.893 | 18.821 | 13.279 | 4.848 | 43.998 |
Total Liabilities | 2309.02 | 2424.33 | 2354.31 | 2595.12 | 3050.16 |
Total Long Term Debt | 861.412 | 844.699 | 923.982 | 684.21 | 688.063 |
Long Term Debt | 861.412 | 844.699 | 923.982 | 684.21 | 688.063 |
Deferred Income Tax | 33.664 | 33.863 | 34.658 | 35.552 | 38.928 |
Minority Interest | 11.827 | 12.02 | 12.205 | 12.399 | 12.594 |
Other Liabilities, Total | 179.512 | 175.249 | 179.458 | 194.292 | 214.45 |
Total Equity | 2524.02 | 2505.56 | 2544.62 | 2672.52 | 2770.91 |
Common Stock | 0.164 | 0.164 | 0.163 | 0.162 | 0.159 |
Additional Paid-In Capital | 1738.54 | 1725.57 | 1714.88 | 1690.88 | 1675.69 |
Retained Earnings (Accumulated Deficit) | 739.162 | 736.187 | 806.128 | 942.848 | 1018.4 |
Other Equity, Total | 127.565 | 120.549 | 96.252 | 105.796 | 135.584 |
Total Liabilities & Shareholders’ Equity | 4833.05 | 4929.89 | 4898.93 | 5267.64 | 5821.07 |
Total Common Shares Outstanding | 244.152 | 244.152 | 244.152 | 251.201 | 251.201 |
Treasury Stock - Common | -81.408 | -76.905 | -72.803 | -67.163 | -58.918 |
Note Receivable - Long Term | 6.832 | 6.746 | 6.348 | 6.333 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -289.001 | 136.952 | 229.706 | 573.371 | 336.32 |
Cash From Operating Activities | -787.643 | -232.435 | 157.302 | 427.999 | 707.605 |
Cash From Operating Activities | 58.618 | 51.884 | 27.129 | 9.409 | 5.773 |
Deferred Taxes | -65.22 | -18.694 | -10.442 | -27.8 | -32.895 |
Non-Cash Items | 71.759 | 122.289 | 120.876 | 114.907 | 138.256 |
Cash Taxes Paid | 3.443 | 74.377 | 82.406 | 91.732 | 52.063 |
Changes in Working Capital | -563.799 | -524.866 | -209.967 | -249.694 | 259.708 |
Cash From Investing Activities | -42.258 | -1069.29 | -206.88 | -112.703 | -324.841 |
Capital Expenditures | -9.92 | -53.082 | -84.774 | -46.121 | -69.153 |
Other Investing Cash Flow Items, Total | -32.338 | -1016.21 | -122.106 | -66.582 | -255.688 |
Cash From Financing Activities | 289.198 | 551.077 | 564.671 | 25.609 | 639.17 |
Issuance (Retirement) of Stock, Net | -53.216 | -8.298 | 0.933 | 652.391 | |
Issuance (Retirement) of Debt, Net | 421.624 | 520.18 | 564.671 | -20 | -13.221 |
Foreign Exchange Effects | 4.504 | -15.564 | -43.334 | 11.274 | 60.357 |
Net Change in Cash | -536.199 | -766.211 | 471.759 | 352.179 | 1082.29 |
Amortization | 7.806 | 0.443 | |||
Cash Interest Paid | 55.847 | 47.132 | 14.858 | 0.286 | 1.31 |
Financing Cash Flow Items | -39.195 | 39.195 | 44.676 | ||
Total Cash Dividends Paid | -40.015 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Allspring Global Investments, LLC | Investment Advisor/Hedge Fund | 16.1779 | 5134210 | 0 | 2023-09-30 | LOW |
Fidelity International | Investment Advisor | 5.7593 | 1827770 | -170313 | 2023-06-30 | LOW |
FIL Investment Management (Hong Kong) Limited | Investment Advisor | 3.8846 | 1232834 | -37407 | 2023-06-30 | HIGH |
Huang (Wang) | Individual Investor | 3.3559 | 1065019 | 0 | 2022-12-31 | |
Florida State Board of Administration | Pension Fund | 1.4779 | 469042 | -20500 | 2022-09-30 | LOW |
SEI Investments Management Corporation | Investment Advisor/Hedge Fund | 1.1309 | 358906 | 0 | 2023-06-30 | LOW |
Axxion S.A. | Investment Advisor | 0.4726 | 150000 | 50000 | 2023-09-30 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.3094 | 98200 | -1400 | 2023-06-30 | HIGH |
Citadel Advisors LLC | Hedge Fund | 0.2891 | 91762 | 30192 | 2023-06-30 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.0984 | 31239 | -8855 | 2023-06-30 | MED |
Mandatum Asset Management Ltd | Investment Advisor | 0.0851 | 27000 | 0 | 2023-09-30 | MED |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.0772 | 24510 | -50153 | 2023-06-30 | LOW |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 0.0766 | 24307 | -3647 | 2023-06-30 | MED |
LPL Financial LLC | Investment Advisor | 0.0687 | 21803 | -1350 | 2023-06-30 | LOW |
Millennium Management LLC | Hedge Fund | 0.0536 | 16997 | -6656 | 2023-06-30 | HIGH |
Hansen & Heinrich Aktiengesellschaft | Investment Advisor | 0.0473 | 15000 | 0 | 2022-04-30 | MED |
Morgan Stanley & Co. LLC | Research Firm | 0.0472 | 14968 | -6616 | 2023-06-30 | MED |
Gesinter S.G.I.I.C., S.A. | Investment Advisor | 0.0315 | 9999 | -11583 | 2023-06-30 | HIGH |
Osaic Holdings, Inc. | Investment Advisor | 0.0115 | 3640 | -145 | 2023-06-30 | LOW |
Rhumbline Advisers Ltd. Partnership | Investment Advisor | 0.0107 | 3390 | 3390 | 2023-06-30 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Zepp Health Company profile
About Zepp Health Corp - ADR
Zepp Health Corp, formerly Huami Corp, is a company committed to connect health with technology. It has developed a platform of proprietary technology including artificial intelligence (AI) chips, biometric sensors, and health data algorithms. It is engaged in developing smart wearable technology. It designs and develops biometric and activity data-driven fitness and smart watches. It markets its products under the brand name, Amazfit and is the sole partner for Xiaomi wearable products. The products includes Amazfit BIP, Amazfit pace, Amazfit equator, Amazfit ARC, and accessories, such as sports bands, watch straps, ear buds, charging units, and core trackers. The smart watches provides activity tracking, sleep tracking, smart notifications from mobile devices, GPS, heart rate sensing, water resistance, wireless syncing with mobile phones. It also provides a mobile application to keep track of the fitness information, set alarms and receive call notifications on the smart watch.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Zepp Health Corp - ADR revenues decreased 3% to RMB6.25B. Net income decreased 40% to RMB137.8M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Interest income decrease of 64% to RMB16.7M (income), Gain from fair value change of long-term decrease from RMB12.3M (income) to RMB0K.
Industry: | Phones & Handheld Devices (NEC) |
Building B2, Zhong'an Chuanggu Technology Park, No.900 Wangjiang West Rd
HEFEI
ANHUI 230088
CN
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com